Literature DB >> 18595531

Reduced interleukin-17 expression of Burkholderia pseudomallei-infected peripheral blood mononuclear cells of diabetic patients.

Sutatip Pongcharoen1, Pannika Niumsup Ritvirool, Donruedee Sanguansermsri, Pairat Chanchan, Poj Jienmongkol, Puntharee Butkhamchot, Prateep Warnnissorn, Napatawn Banchuin, Stitaya Sirisinha.   

Abstract

Burkholderia pseudomallei is the causative agent of melioidosis. One of the main risk factors for B. pseudomallei infection in endemic areas is diabetes mellitus. The present study investigated IL-17 mRNA and protein expression by peripheral blood mononuclear cells in response to B. pseudomallei infection in 10 diabetic patients in comparison to 10 healthy blood donors. The IL-17 expression in diabetic patients was significantly lower (p < 0.05) than in the controls. However, IL-23 mRNA expression of the 2 groups was comparable. The present findings suggest that melioidosis affects T cell IL-17 production and that patients with diabetes mellitus have a defective IL-17 production in response to this type of infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18595531

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  6 in total

1.  Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity.

Authors:  Jodie Morris; Natasha Williams; Catherine Rush; Brenda Govan; Kunwarjit Sangla; Robert Norton; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

2.  Delayed activation of host innate immune pathways in streptozotocin-induced diabetic hosts leads to more severe disease during infection with Burkholderia pseudomallei.

Authors:  Chui-Yoke Chin; Denise M Monack; Sheila Nathan
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

3.  Application of polymerase chain reaction to detect burkholderia pseudomallei and Brucella species in buffy coat from patients with febrile illness among rural and peri-urban population.

Authors:  Balaji Nandagopal; Sathish Sankar; Karthikeyan Lingesan; Kc Appu; Gopalan Sridharan; Anilkumar Gopinathan
Journal:  J Glob Infect Dis       Date:  2012-01

Review 4.  A Protective Role of Glibenclamide in Inflammation-Associated Injury.

Authors:  Gensheng Zhang; Xiuhui Lin; Shufang Zhang; Huiqing Xiu; Chuli Pan; Wei Cui
Journal:  Mediators Inflamm       Date:  2017-06-27       Impact factor: 4.711

5.  Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed TH1-TH17 Immunity, Correlated with Increased Protection against Burkholderia pseudomallei.

Authors:  Daniel Tapia; Javier I Sanchez-Villamil; Heather L Stevenson; Alfredo G Torres
Journal:  mBio       Date:  2021-06-29       Impact factor: 7.867

6.  Glyburide reduces bacterial dissemination in a mouse model of melioidosis.

Authors:  Gavin C K W Koh; Tassili A Weehuizen; Katrin Breitbach; Kathrin Krause; Hanna K de Jong; Liesbeth M Kager; Arjan J Hoogendijk; Antje Bast; Sharon J Peacock; Tom van der Poll; Ivo Steinmetz; W Joost Wiersinga
Journal:  PLoS Negl Trop Dis       Date:  2013-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.